Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

5-HT1B antagonists from SmithKline Beecham

July 14, 1997

Newer valpromide analogues for treating epilepsy

July 14, 1997

Once-daily extended-release venlafaxine evaluated in depression

July 11, 1997

Pharmacokinetic, drug interaction and clinical results with ziprasidone

July 11, 1997

Phase II/III results for Seroquel

July 11, 1997

DuPont Merck and Elan enter alliance for copromotion of Parkinson's disease products

July 11, 1997

German introduction for Parkinsan

July 11, 1997

c-fos gene is implicated in pain states

July 10, 1997

NK1 receptor antagonists for pain

July 10, 1997

SNX-111 and SNX-230, analgesic conopeptides and calcium channel blockers

July 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...